Searched for
TEVA WATSON SANDOZ
Lupin gets USFDA approval for oral contraceptive tabletsLupin today said it has received US health regulator's approval to market Drospirenone and Ethinyl Estradiol Tablets, an oral contraceptive...- Strides Arcolab may fetch Rs 1250 cr from sale of domestic unitsStrides has received offers from a variety of global generic drug manufacturers as well as some Indian drug-makers and PE funds for the bus...
- Now, generic drug cos pop patent pillGeneric drug companies too have joined the rush to seek patents for drugs in India.
- TEVA TO buy local unit for Rs 400 crThe world’s largest generic drug manufacturer Teva may be close to acquiring domestic company Saraca Labs’ manufacturing plant in Hyderabad...
- Glenmark gets US nod for pravastatin sodiumGlenmark Pharmaceuticals announced on Wednesday that it had received approval in the US to market a generic version of Bristol Myers Squibb...
- Israel's Teva moves court against Indian cos for patent violationIsrael’s Teva Pharmaceutical Industries Ltd has moved court against five leading Indian companies - Cipla, Zydus Cadila Healthcare, Lupin, ...
- Safe & steady strategy gives Cipla lead over RanbaxySome years ago, investors were hooked to Ranbaxy Labs’ growth story and the many earnings triggers that lay ahead.
- Matrix deal to trigger M&As in pharma secGlobal majors, Teva, Watson, Barr and Activis are also eyeing mid-sized and large Indian cos.
- Global pharma cos may pop in buyout pillThe high-profile Mylan-Matrix deal is likely to trigger a series of mergers and acquisitions (M&A) in the Indian pharmaceutical market. Aro...
Load More- TEVA TO buy local unit for Rs 400 cr
